Childress Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Buy
3,950
+232
+6% +$82.7K 0.25% 60
2025
Q4
$1.22M Buy
3,718
+1,207
+48% +$383K 0.2% 79
2025
Q3
$709K Buy
2,511
+415
+20% +$120K 0.13% 118
2025
Q2
$585K Buy
2,096
+472
+29% +$134K 0.15% 108
2025
Q1
$506K Sell
1,624
-92
-5% -$27.2K 0.15% 102
2024
Q4
$447K Sell
1,716
-179
-9% -$53.1K 0.12% 109
2024
Q3
$611K Sell
1,895
-87
-4% -$28.5K 0.16% 93
2024
Q2
$619K Buy
1,982
+94
+5% +$27.6K 0.17% 84
2024
Q1
$537K Sell
1,888
-108
-5% -$31.6K 0.16% 89
2023
Q4
$575K Buy
1,996
+2
+0.1% +$545 0.17% 81
2023
Q3
$539K Buy
+1,994
New +$498K 0.18% 81
2023
Q1
Sell
-2,005
Closed -$527K 92
2022
Q4
$527K Sell
2,005
-303
-13% -$81.2K 0.17% 84
2022
Q3
$536K Buy
2,308
+88
+4% +$21.3K 0.21% 78
2022
Q2
$540K Buy
2,220
+126
+6% +$30.9K 0.21% 78
2022
Q1
$507K Buy
2,094
+182
+10% +$41.8K 0.18% 95
2021
Q4
$430K Buy
1,912
+282
+17% +$59.5K 0.18% 101
2021
Q3
$352K Buy
1,630
+52
+3% +$12K 0.14% 127
2021
Q2
$384K Sell
1,578
-557
-26% -$137K 0.17% 100
2021
Q1
$531K Buy
2,135
+673
+46% +$161K 0.24% 81
2020
Q4
$336K Buy
+1,462
New +$337K 0.2% 61

Other funds holding AMGN

Childress Capital Advisors's AMGN Position: Q1 2026 in Review

Childress Capital Advisors increased its Amgen (AMGN) stake by 6.2% in Q1 2026, buying an estimated $82.7K and bringing the position to 3,950 shares worth $1.39M. The position accounts for 0.25% of the portfolio, ranked #60.

Childress Capital Advisors first reported a position in AMGN in Q4 2020 and has held it in 20 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Childress Capital Advisors held 3,950 shares of Amgen worth $1.39M as of Q1 2026.
  • Childress Capital Advisors bought 232 Amgen shares in Q1 2026, an estimated $82.7K.
  • Amgen made up 0.25% of Childress Capital Advisors's portfolio in Q1 2026, its #60 holding.
  • Childress Capital Advisors first reported a position in Amgen in Q4 2020 and has held it in 20 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.